does pfizer make glp 1 drugs Phase IIb Data Support Monthly GLP-1 Dosing for Obesity What is the pipeline for
Description
Abstract Glucagon-like peptide-1 medicines are being prescribed to growing numbers of patients worldwide, for type 2 diabetes, obesity and associated comorbidities, including cardiovascular disease, peripheral artery disease and obstructive sleep apnea, and are revolutionizing public health strategies for these conditions
Feeling fuller can lead to reduced caloric intake and improved glucose tolerance
Recent guidance recommends individualized perioperative plans potentially holding doses before elective surgery
Therefore, women of childbearing age should be advised that significant weight loss may increase fertility, requiring effective contraception
